Friday - March 29, 2024
REPS. DINGELL, STUPAK RESPOND TO FDA'S RANBAXY ANNOUNCEMENT
September 16, 2008
WASHINGTON, Sept. 16 -- The House Energy & Commerce Committee issued the following news release:

Democratic leaders of the House Committee on Energy and Commerce reacted to the Food and Drug Administration's (FDA) announcement today that it would partially restrict imports manufactured by Ranbaxy, Inc. at two of the company's plants in India. In July, Reps. John D. Dingell (D-MI), Chairman of the Committee, and Bart Stupak (D-MI), Chairman of its Subcommittee on Oversight and . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products